Skip to Main Content

Paper Details

Using artificial intelligence to learn optimal regimen plan for Alzheimer's disease.
J Am Med Inform Assoc
2
2023
AD, AD-Depression, Alzheimer's Disease, Alzheimer's disease, Hypertension, cholinesterase, depression, hypertension, memantine, neurological disorder, patient, patients
Alzheimer Disease, Artificial Intelligence, Cholinesterase Inhibitors, Humans, Learning, Memantine
Author NameAffiliation
Kritib BhattaraiLuther College
Sivaraman RajaganapathyMayo Clinic
Trisha DasUniversity of Illinois Urbana-Champaign
Yejin KimUniversity of Texas Health Science Center
Yongbin ChenMayo Clinic
Qiying DaiMayo Clinic
Xiaoyang LiMayo Clinic
Xiaoqian JiangUniversity of Texas Health Science Center
Nansu ZongMayo Clinic
Nansu ZongMayo Clinic
  • 1 - 10

Datasets

Release 1.2